The global primary sclerosing cholangitis (PSC) market is poised for substantial growth, projected to reach US$ 314.26 million by 2033, with a compound annual growth rate (CAGR) of 7.6% from 2023 to 2033. This remarkable expansion is driven by the escalating prevalence of liver diseases worldwide and the burgeoning trend of alcohol consumption. In 2023, …
Tag Archives: Primary Sclerosing Cholangitis (PSC) Market
Global Primary Sclerosing Cholangitis (PSC) Market is poised to surpass US$ 314.26 Million by 2033, as projected by FMI
The global primary sclerosing cholangitis (PSC) market is expected to be worth US$ 151.07 million in 2023. Because of rising alcohol consumption, the overall demand for Primary Sclerosing Cholangitis (PSC) is expected to grow at a CAGR of 7.6% between 2023 and 2033, totaling around US$ 314.26 Million by 2033. The Primary Sclerosing Cholangitis (PSC) …